Rahimian Sana, Najafi Hossein, Afzali Baran, Doroudian Mohammad
Department of Cell and Molecular Sciences, Faculty of Biological Sciences, Kharazmi University, Tehran 14911-15719, Iran.
Biomedicines. 2024 Jan 7;12(1):123. doi: 10.3390/biomedicines12010123.
Lung cancer demands innovative approaches for early detection and targeted treatment. In addressing this urgent need, exosomes play a pivotal role in revolutionizing both the early detection and targeted treatment of lung cancer. Their remarkable capacity to encapsulate a diverse range of biomolecules, traverse biological barriers, and be engineered with specific targeting molecules makes them highly promising for both diagnostic markers and precise drug delivery to cancer cells. Furthermore, an in-depth analysis of exosomal content and biogenesis offers crucial insights into the molecular profile of lung tumors. This knowledge holds significant potential for the development of targeted therapies and innovative diagnostic strategies for cancer. Despite notable progress in this field, challenges in standardization and cargo loading persist. Collaborative research efforts are imperative to maximize the potential of exosomes and advance the field of precision medicine for the benefit of lung cancer patients.
肺癌需要创新的早期检测和靶向治疗方法。为满足这一迫切需求,外泌体在彻底改变肺癌的早期检测和靶向治疗方面发挥着关键作用。它们具有包裹多种生物分子、穿越生物屏障以及用特定靶向分子进行工程改造的非凡能力,这使其在作为诊断标志物和向癌细胞精确给药方面极具潜力。此外,对外泌体内容物和生物发生的深入分析为肺肿瘤的分子特征提供了关键见解。这些知识对于开发癌症的靶向治疗和创新诊断策略具有巨大潜力。尽管该领域取得了显著进展,但标准化和货物装载方面的挑战依然存在。必须开展合作研究,以最大限度地发挥外泌体的潜力,并推动精准医学领域的发展,造福肺癌患者。